# Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

> **NCT05227846** · PHASE1 · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **BIOLOGICAL:** Human Umbilical Cord-derived Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT05227846
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-22
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-03-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227846, "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05227846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*